IndraLab

Statements

CYLD inhibits gefitinib. 1 / 1

| 1

reach

"Reduced expression of CYLD promotes cell survival and inflammation in gefitinib treated NSCLC PC-9 cells : targeting CYLD may be beneficial for acquired resistance to gefitinib therapy."

32441799

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

CYLD inhibits gefitinib. 1 / 1

INDRA sources:

Databases

Reading